Employees: 11 (2023.0)Legal category: 5485Size: PMECreation date: 2001-08-31 (24 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: PIERREFITTE-SUR-SEINE (93380), Seine-Saint-Denis
SELARL PHARMACIE CENTRALE DE LA GARE : revenue, balance sheet and financial ratios
SELARL PHARMACIE CENTRALE DE LA GARE is a French company
founded 24 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in PIERREFITTE-SUR-SEINE (93380),
this company of category PME
shows in 2015 a revenue of 3.3 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SELARL PHARMACIE CENTRALE DE LA GARE (SIREN 439193889)
Indicator
2023
2020
2019
2018
2017
2016
2015
2014
2013
2012
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
3 322 986 €
3 457 248 €
3 382 133 €
1 595 641 €
Net income
210 837 €
80 559 €
132 316 €
130 126 €
126 203 €
101 154 €
177 438 €
106 722 €
115 276 €
476 299 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
192 120 €
134 407 €
138 207 €
74 937 €
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
5.3%
3.1%
3.4%
29.9%
Revenue and income statement
In 2023, SELARL PHARMACIE CENTRALE DE LA GARE generates positive net income of 211 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2012-2023: 476 k€ -> 211 k€.
Net income (2023)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
210 837 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 457%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 10%. Low autonomy: the company heavily depends on external financing (banks, suppliers).
Debt ratio (2023)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
456.513%
Financial autonomy (2023)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
9.633%
Asset age ratio (2023)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution SELARL PHARMACIE CENTRALE DE LA GARE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2012
2013
2014
2015
2016
2017
2018
2019
2020
2023
Debt ratio
0.0
973.824
925.11
0.0
0.0
377.491
386.231
281.995
1263.629
456.513
Financial autonomy
19.415
7.166
7.092
11.674
10.859
12.611
14.412
20.627
4.734
9.633
Repayment capacity
0.0
10.429
9.544
0.0
None
None
None
None
None
None
Cash flow / Revenue
-2.952%
4.201%
4.118%
4.49%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
456.512023
2019
2020
2023
Q1: 20.09
Med: 66.92
Q3: 169.24
Average
In 2023, the debt ratio of SELARL PHARMACIE CENTRALE... (456.51) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
9.63%2023
2019
2020
2023
Q1: 28.72%
Med: 48.51%
Q3: 68.17%
Average
In 2023, the financial autonomy of SELARL PHARMACIE CENTRALE... (9.6%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 164.32. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2023)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
164.317
Liquidity indicators evolution SELARL PHARMACIE CENTRALE DE LA GARE
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2012
2013
2014
2015
2016
2017
2018
2019
2020
2023
Liquidity ratio
364.847
204.998
185.574
238.765
209.65
129.663
155.238
247.959
135.074
164.317
Interest coverage
76.758
50.564
53.34
38.035
None
None
None
None
None
None
Sector positioning
Liquidity ratio
164.322023
2019
2020
2023
Q1: 135.25
Med: 189.78
Q3: 270.35
Average-37 pts over 3 years
In 2023, the liquidity ratio of SELARL PHARMACIE CENTRALE... (164.32) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2023)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2023)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2023)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2023)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution SELARL PHARMACIE CENTRALE DE LA GARE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2012
2013
2014
2015
2016
2017
2018
2019
2020
2023
Operating WCR
1 563 122 €
920 786 €
875 479 €
1 089 208 €
0 €
0 €
0 €
0 €
0 €
0 €
Inventory turnover (days)
73
37
37
40
0
0
0
0
0
0
Customer payment term (days)
30
18
18
13
0
0
0
0
0
0
Supplier payment term (days)
100
40
46
55
0
0
0
0
0
0
Positioning of SELARL PHARMACIE CENTRALE DE LA GARE in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 220 transactions of similar company sales
in 2023,
the value of SELARL PHARMACIE CENTRALE DE LA GARE is estimated at
2 487 766 €
(range 1 512 929€ - 3 497 240€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2023
220 transactions
1512k€2487k€3497k€
2 487 766 €Range: 1 512 929€ - 3 497 240€
NAF 5 année 2023
Valuation method used
Net Income Multiple
210 837 €
×
11.8x
=2 487 766 €
Range: 1 512 930€ - 3 497 241€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 220 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SELARL PHARMACIE CENTRALE DE LA GARE with other companies in the same sector:
Frequently asked questions about SELARL PHARMACIE CENTRALE DE LA GARE
What is the revenue of SELARL PHARMACIE CENTRALE DE LA GARE ?
The revenue of SELARL PHARMACIE CENTRALE DE LA GARE in 2015 is 3.3 M€.
Is SELARL PHARMACIE CENTRALE DE LA GARE profitable?
Yes, SELARL PHARMACIE CENTRALE DE LA GARE generated a net profit of 211 k€ in 2023.
Where is the headquarters of SELARL PHARMACIE CENTRALE DE LA GARE ?
The headquarters of SELARL PHARMACIE CENTRALE DE LA GARE is located in PIERREFITTE-SUR-SEINE (93380), in the department Seine-Saint-Denis.
Where to find the tax return of SELARL PHARMACIE CENTRALE DE LA GARE ?
The tax return of SELARL PHARMACIE CENTRALE DE LA GARE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SELARL PHARMACIE CENTRALE DE LA GARE operate?
SELARL PHARMACIE CENTRALE DE LA GARE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart